{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:49:53Z","timestamp":1788569393544,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.canlet.2012.12.018","type":"journal-article","created":{"date-parts":[[2013,1,3]],"date-time":"2013-01-03T19:10:09Z","timestamp":1357240209000},"page":"32-35","source":"Crossref","is-referenced-by-count":21,"title":["Delayed cytogenetic and major molecular responses associated to increased BMI at baseline in chronic myeloid leukemia patients treated with imatinib"],"prefix":"10.1016","volume":"333","author":[{"given":"Massimo","family":"Breccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Loglisci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Salaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Serrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Diverio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Latagliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Alimena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.canlet.2012.12.018_b0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1470-2045(02)00849-5","article-title":"Overweight, obesity, and cancer risk","volume":"3","author":"Bianchini","year":"2002","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2012.12.018_b0010","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ejca.2008.11.004","article-title":"Overweight, obesity and risk of haematological malignancies: a cohort study of Swedish and Finnish twins","volume":"45","author":"Soderberg","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"17","key":"10.1016\/j.canlet.2012.12.018_b0015","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.canlet.2012.12.018_b0020","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1002\/ijc.23176","article-title":"Overweight and obesity and incidence of leukemia: a meta-analysis of cohort studies","volume":"122","author":"Larsson","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.canlet.2012.12.018_b0025","first-page":"994","article-title":"Obesity and breast cancer","volume":"25","author":"Ligibel","year":"2011","journal-title":"Oncology (Williston Park)"},{"issue":"19","key":"10.1016\/j.canlet.2012.12.018_b0030","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/jnci\/djg060","article-title":"Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer","volume":"95","author":"Dignam","year":"2003","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.canlet.2012.12.018_b0035","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1158\/1055-9965.EPI-09-0028","article-title":"Obesity, weight gain, and risk of chronic myeloid leukemia","volume":"18","author":"Strom","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"24","key":"10.1016\/j.canlet.2012.12.018_b0040","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1182\/blood-2009-07-232595","article-title":"GIMEMA CML Working Party. Nilotinib for the frontline treatment of Ph(+) chronic myeloid leukemia","volume":"114","author":"Rosti","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2012.12.018_b0045","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood.V118.21.453.453","article-title":"Alternating nilotinib 400 mg twice daily and imatinib 400 mg once daily as frontline treatment of Ph+ chronic myeloid leukemia. A phase 2 multicentric study of the GIMEMA CML Working Party","volume":"118","author":"Castagnetti","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2012.12.018_b0050","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1182\/blood.V63.4.789.789","article-title":"Prognostic discrimination in \u201cgood-risk\u201d chronic granulocytic leukemia","volume":"63","author":"Sokal","year":"1984","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.canlet.2012.12.018_b0055","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1182\/blood-2010-12-319038","article-title":"Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score","volume":"118","author":"Hasford","year":"2011","journal-title":"Blood"},{"issue":"35","key":"10.1016\/j.canlet.2012.12.018_b0060","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1200\/JCO.2009.25.0779","article-title":"European LeukemiaNet. Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet","volume":"27","author":"Baccarani","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2012.12.018_b0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12185-011-0980-y","article-title":"The role of body mass index and other body composition parameters in early post-transplant complications in patients undergoing allogeneic stem cell transplantation with busulfan-cyclophosphamide conditioning","volume":"95","author":"Sucak","year":"2012","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.canlet.2012.12.018_b0070","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1161\/ATVBAHA.107.147835","article-title":"Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis","volume":"27","author":"Gustafson","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.canlet.2012.12.018_b0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.yexcr.2008.10.036","article-title":"Macrophage-conditioned medium inhibits differentiation-induced Rb phosphorylation in 3T3-L1 preadipocytes","volume":"315","author":"Yarmo","year":"2009","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.canlet.2012.12.018_b0080","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s00125-006-0253-0","article-title":"Macrophage-conditioned medium inhibits the differentiation of 3T3-L1 and human abdominal preadipocytes","volume":"49","author":"Constant","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.canlet.2012.12.018_b0085","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.metabol.2007.11.005","article-title":"The antiadipogenic effect of macrophage-conditioned medium depends on ERK1\/2 activation","volume":"57","author":"Constant","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.canlet.2012.12.018_b0090","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1210\/en.2006-0687","article-title":"Macrophage-secreted factors impair human adipogenesis: involvement of proinflammatory state in preadipocytes","volume":"148","author":"Lacasa","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.canlet.2012.12.018_b0095","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1210\/jc.2008-0044","article-title":"Evidence in situ proliferation of adult adipose tissue-derived progenitors cells: influence of fat mass microenvironment and growth","volume":"93","author":"Maumus","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.canlet.2012.12.018_b0100","doi-asserted-by":"crossref","first-page":"C757","DOI":"10.1152\/ajpcell.00617.2008","article-title":"Preadipocyte apoptosis is prevented by macrophage-conditioned medium in a PDGF-dependent manner","volume":"296","author":"Molgat","year":"2009","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.canlet.2012.12.018_b0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/JME-12-0003","article-title":"Suppression of PDGF induced PI 3 kinase activity by imatinib promotes adipogenesis and adiponectin secretion","volume":"48","author":"Fitter","year":"2012","journal-title":"J. Mol. Endocrinol."},{"issue":"10","key":"10.1016\/j.canlet.2012.12.018_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0025651","article-title":"Leptin reverts pro-apoptotic and antiproliferative effects of \u03b1-linoleic acids in BCR-ABL positive leukemic cells: involvement of PI3K pathway","volume":"6","author":"Beaulieu","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.canlet.2012.12.018_b0115","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/sj.leu.2404549","article-title":"Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase","volume":"21","author":"Diaz-Blanco","year":"2007","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.canlet.2012.12.018_b0120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.leukres.2009.08.031","article-title":"Nilotinib: a second-generation tyrosine kinase inhibitor for chronic myeloid leukemia","volume":"34","author":"Breccia","year":"2010","journal-title":"Leuk. Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512007355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383512007355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,19]],"date-time":"2020-07-19T19:16:40Z","timestamp":1595186200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383512007355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0304383512007355"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2012.12.018","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}